WHO Prequalification (PQ) – Page 3

CAPA effectiveness doubted during WHO PQ assessment – preventing PQ suspension

Understanding the symptoms that indicate potential CAPA failures is crucial for timely intervention. These manifestations can vary from operational inefficiencies to outright non-compliance with regulatory standards. Key symptoms include:Click to…

Stability data gaps during inspection preparation – CAPA expectations for PQ approval

Identifying the symptoms of stability data gaps requires vigilant observation in both production and laboratory settings. Symptoms can manifest through various indicators:Click to read the full article.

Manufacturing site not PQ-ready during dossier submission – PQ assessment risk and mitigation

Identifying the symptoms or signals of unpreparedness can prevent further complications throughout the production process. Key indications may include:Click to read the full article.

API change not reported during WHO PQ assessment – CAPA expectations for PQ approval

Before a deeper exploration into causes, recognizing the symptoms signaling an unreported API change is paramount. The following signals may indicate compliance issues:Click to read the full article.

API change not reported during WHO PQ assessment – PQ assessment risk and mitigation

Recognizing early warning signs of unreported API changes is crucial for maintaining product integrity. Symptoms may manifest in various forms, including:Click to read the full article.

PQ dossier deficiency during WHO PQ assessment – CAPA expectations for PQ approval

Early detection of PQ dossier deficiencies often arises from multiple signals in the lab or production area. A well-defined set of symptoms can facilitate immediate actions and prevent further operational…

API change not reported during inspection preparation – PQ assessment risk and mitigation

Recognizing early signals of API changes not reported during inspection preparation is key to preventing regulatory risks. Symptoms often manifest as deviations or abnormalities during routine operations. Here are signs…

Stability data gaps during dossier submission – documentation gaps reviewers flag

Real-world observations are critical when diagnosing stability data gaps. Here are common symptoms that may signal underlying issues:Click to read the full article.

Stability data gaps during dossier submission – preventing PQ suspension

The first step in identifying stability data gaps is recognizing the symptoms or signals that may arise during manufacturing or laboratory operations. Here are common indicators:Click to read the full…

CAPA effectiveness doubted during requalification – how to defend manufacturing readiness

Identifying key symptoms or signals that suggest CAPA effectiveness is under examination is crucial for timely response. Common indicators include:Click to read the full article.

Deviation history questioned during dossier submission – preventing PQ suspension

Identifying symptoms or signals associated with deviations is crucial for timely intervention. Here are some common indicators you may observe:Click to read the full article.

Stability data gaps during requalification – how to defend manufacturing readiness

Identifying symptoms early can prevent minor issues from escalating into major compliance violations. When reassessing stability data during requalification, the following red flags may signal a gap or inconsistency:Click to…